- Report
- July 2025
- 193 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 196 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 186 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- May 2025
- 134 Pages
Global
From €2635EUR$2,999USD£2,273GBP
- Report
- January 2025
- 135 Pages
Global
From €2635EUR$2,999USD£2,273GBP
- Report
- March 2025
- 147 Pages
Global
From €2635EUR$2,999USD£2,273GBP
- Report
- June 2025
- 400 Pages
Global
From €4349EUR$4,949USD£3,751GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1318EUR$1,500USD£1,137GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1098EUR$1,250USD£947GBP
- Report
- October 2024
- 169 Pages
Global
From €6985EUR$7,950USD£6,026GBP
- Report
- February 2025
- 180 Pages
Global
From €3361EUR$3,825USD£2,899GBP
€3954EUR$4,500USD£3,411GBP
- Report
- January 2025
- 183 Pages
Global
From €3361EUR$3,825USD£2,899GBP
€3954EUR$4,500USD£3,411GBP
- Report
- September 2024
- 183 Pages
Global
From €3361EUR$3,825USD£2,899GBP
€3954EUR$4,500USD£3,411GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1757EUR$2,000USD£1,516GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1098EUR$1,250USD£947GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1098EUR$1,250USD£947GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1318EUR$1,500USD£1,137GBP
- Report
- July 2024
- 155 Pages
Global
From €3734EUR$4,250USD£3,221GBP
- Report
- June 2025
- 150 Pages
Global
From €2372EUR$2,699USD£2,046GBP
- Report
- June 2025
- 150 Pages
Global
From €2372EUR$2,699USD£2,046GBP

Proton Pump Inhibitors (PPIs) are a class of drugs used to treat Gastrointestinal (GI) disorders. They work by reducing the amount of acid produced in the stomach, which helps to relieve symptoms of acid reflux, heartburn, and other GI conditions. PPIs are available in both prescription and over-the-counter forms, and are often used in combination with other medications to treat more severe GI conditions. Common side effects of PPIs include headache, nausea, and diarrhea.
PPIs are among the most widely prescribed drugs in the world, and are used to treat a variety of GI conditions. They are often used as a first-line treatment for acid reflux and other GI disorders, and are also used to prevent and treat ulcers.
Some of the major companies in the PPI market include AstraZeneca, Pfizer, Takeda, and GlaxoSmithKline. These companies produce a variety of PPIs, including omeprazole, lansoprazole, and pantoprazole. Show Less Read more